Cutaneous T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Cutaneous T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Tissue Repository: CTCL Collection Protocol
This clinical trial update describes a tissue repository protocol for collecting samples related to cutaneous T-cell lymphoma (CTCL) and rel…
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma [Phase 2]
Phase 2 trial evaluating the combination of extracorporeal photopheresis and mogamulizumab for erythrodermic cutaneous T-cell lymphoma, curr…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: StrataCTX® as a Steroid Sparing Device [NA]
This clinical trial update reports that StrataCTX is being studied as a steroid-sparing device for cutaneous T-cell lymphoma and that the tr…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Photopheresis in Early-stage Mycosis Fungoides [Phase 2]
Phase 2 trial evaluating photopheresis in early-stage mycosis fungoides (cutaneous T cell lymphoma) is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of ST-001 nanoFenretinide for relapsed/refractory T-cell non-Hodgkin lymphoma is currently recruiting, targeting multiple T-ce…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Brentuximab Vedotin in CutAneous T-cell Lymphomas (CTCL): Post-allogeneic Hematopoietic Stem Cell Transplant Maintenance [Phase 3]
Phase 3 trial evaluating Brentuximab Vedotin as maintenance therapy after allogeneic hematopoietic stem cell transplant in cutaneous T-cell …
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Local Registry of Primary Cutaneous T-cell Lymphomas
A local registry study for Primary cutaneous T-cell lymphoma is currently recruiting at Fondazione IRCCS Policlinico San Matteo di Pavia.
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the combination of duvelisib and venetoclax in relapsed or refractory peripheral T-cell lymphoma, w…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System [Phase 1]
Phase 1 trial investigating safety and activity of a novel TNFR2 inhibitor in adults with non-Hodgkin lymphoma, including cutaneous T-cell l…
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: Long-term Assessment of Chlormethine Gel in Mycosis Fungoides
This clinical trial update outlines a long-term assessment of chlormethine gel (mechlorethamine) for treating mycosis fungoides, a form of c…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Combating Cancer-Related Fatigue: A Personalized Supportive Care Program [NA]
This clinical trial update reports a UNC Lineberger Comprehensive Cancer Center study recruiting participants for a personalized supportive …
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating CD5-targeted CAR T-cell therapy for relapsed/refractory T-cell lymphomas is currently recruiting in Be…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Skin Barrier and Microbiome of CTCL Patients
The trial update reports on a study evaluating skin barrier function and the skin microbiome in patients with cutaneous T-cell lymphoma (CTC…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating CD7-directed CAR T-cell therapy for relapsed/refractory T-cell lymphomas (including PTCL and CTC…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL
A clinical trial update describes novel flow-cytometry approaches for enhanced detection of tumor cells in cutaneous T-cell lymphoma (CTCL).…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies [Phase 1]
A Phase 1 clinical study evaluating the CD70-targeted agent CHT101 in relapsed or refractory hematologic malignancies is currently recruitin…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies [Phase 1]
Phase 1 clinical trial update for BP1002 in advanced lymphoid malignancies across several B-cell and T-cell lymphomas; trial status is activ…
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: A Trial Assessing the Effect of Pembrolizumab Combined with Radiotherapy in Patients with Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS) [Phase 2]
A Phase 2 clinical trial evaluating pembrolizumab in combination with radiotherapy for relapsed, refractory cutaneous T-cell lymphoma, speci…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy [NA]
ClinicalTrials.gov entry MORPHEE investigates mechanisms of cell death induced by extracorporeal photochemotherapy, with conditions includin…
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma [Phase 2]
A Phase 2 clinical trial of IPH4102 (lacutamab) alone or in combination with chemotherapy is evaluating advanced T-cell lymphomas, including…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Pilot Study to Characterize the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of CLn® Skin Care Body Wash
Pilot study to characterize the microbiome in Cutaneous T Cell Lymphoma skin lesions before and after using CLn Skin Care Body Wash; trial s…
-
CLINICAL_TRIALS research · 2024-10-21Clinical Trial Update: Evaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Residual Disease: a Prospective and Multicenter Study
Prospective multicenter study evaluating flow cytometry detection of the KIR3DL2 marker for diagnosing Sézary syndrome, assessing therapeuti…
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma [NA]
This clinical trial update describes a pilot study using a microdevice to screen candidate drugs in cutaneous lesions from patients with cut…
-
CLINICAL_TRIALS research · 2024-06-13Clinical Trial Update: Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
This clinical trial update describes a retrospective analysis of a drug-metabolizing genotype in cancer patients and analyzes correlations w…
-
CLINICAL_TRIALS research · 2024-05-31Clinical Trial Update: A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma
This clinical trial is investigating molecular-subtyping-based therapeutic strategies for Cutaneous T-cell Lymphoma and is currently recruit…